Old Web
English
Sign In
Acemap
>
authorDetail
>
Y. Szabadkai
Y. Szabadkai
Radioligand
Biology
Receptor
Adenosine receptor
Biochemistry
3
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors.
2006
Purinergic Signalling
Stefania Gessi
Katia Varani
Stefania Merighi
Elena Cattabriga
Y. Szabadkai
Rosario Rizzuto
Karl-Norbert Klotz
Edward Leung
Stephen Maclennan
Pier Giovanni Baraldi
Pier Andrea Borea
Show All
Source
Cite
Save
Citations (0)
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors.
2006
Purinergic Signalling
Stefania Gessi
Katia Varani
Stefania Merighi
Elena Cattabriga
Y. Szabadkai
Rosario Rizzuto
Karl-Norbert Klotz
Edward Leung
Stephen Maclennan
Pier-Giovanni Baraldi
Pier Andrea Borea
Show All
Source
Cite
Save
Citations (0)
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20.
2005
S. Gessi
Katia Varani
Stefania Merighi
Elena Cattabriga
Y. Szabadkai
Rosario Rizzuto
Karl-Norbert Klotz
Edward Leung
Stephen Maclennan
Pier Giovanni Baraldi
Pier Andrea Borea
Show All
Source
Cite
Save
Citations (2)
1